AxoGen Inc (AXGN)

10.55
NASDAQ : Health Care
Prev Close 10.55
Day Low/High 0.00 / 0.00
52 Wk Low/High 4.87 / 11.25
Avg Volume 157.70K
Exchange NASDAQ
Shares Outstanding 32.90M
Market Cap 350.36M
EPS -0.50
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

AxoGen Appoints Ivica Ducic Medical Director

AxoGen Appoints Ivica Ducic Medical Director

Peripheral Nerve Surgery Expert Brings More Than 15 Years of Clinical Experience to AxoGen

AxoGen To Participate At AAHS ASPN ASRM Joint 2017 Annual Meeting

AxoGen To Participate At AAHS ASPN ASRM Joint 2017 Annual Meeting

AxoGen to host expert panel discussion and interactive session on new nerve repair technologies

AxoGen Reaches Analyst Target Price

AxoGen Reaches Analyst Target Price

In recent trading, shares of AxoGen Inc have crossed above the average analyst 12-month target price of $8.92, changing hands for $8.95/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

AxoGen, Inc. Announces Commercial Release And First Clinical Implant Of Avive™ Soft Tissue Membrane

AxoGen, Inc. Announces Commercial Release And First Clinical Implant Of Avive™ Soft Tissue Membrane

Expanded Nerve Product Portfolio and Other Business Updates to be Discussed Today at AxoGen's Analyst & Investor Event

AXGN Crosses Above Average Analyst Target

AXGN Crosses Above Average Analyst Target

In recent trading, shares of AxoGen Inc have crossed above the average analyst 12-month target price of $8.25, changing hands for $8.55/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

AxoGen, Inc. Reports Financial Results For Third Quarter 2016

AxoGen, Inc. Reports Financial Results For Third Quarter 2016

Record revenues of $11.2 million, continued growth in accounts, and increased presence of nerve repair at key medical meetings    

AxoGen, Inc. Announces The Refinancing Of Its Debt Facility

AxoGen, Inc. Announces The Refinancing Of Its Debt Facility

New Agreement Will Replace Existing $25 million Term Loan and Revenue Interest Royalty Agreement, and Reduce Annual Interest Costs by at Least $1.5 Million

Commit To Purchase AxoGen At $7.50, Earn 17.1% Annualized Using Options

Commit To Purchase AxoGen At $7.50, Earn 17.1% Annualized Using Options

Investors considering a purchase of AxoGen Inc stock, but cautious about paying the going market price of $8.77/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the April 2017 put at the $7.50 strike, which has a bid at the time of this writing of 70 cents.

AxoGen, Inc. Appoints Amy Wendell To Board Of Directors  

AxoGen, Inc. Appoints Amy Wendell To Board Of Directors  

Former Covidien Senior Executive Brings More Than 30 Years of Experience to AxoGen Board

AxoGen To Participate At 71st Annual American Society For Surgery Of The Hand Meeting

AxoGen To Participate At 71st Annual American Society For Surgery Of The Hand Meeting

Expanded Role of Nerve Awareness and Repair in 30 Separate Conference Sessions and Presentations

AxoGen, Inc. To Participate At The American Association Of Oral And Maxillofacial Surgeons 98th Annual Meeting

AxoGen, Inc. To Participate At The American Association Of Oral And Maxillofacial Surgeons 98th Annual Meeting

Increasing Awareness of Nerve Injury and Repair in Multiple Conference Presentations

AxoGen, Inc. Reports Financial Results For Second Quarter 2016

AxoGen, Inc. Reports Financial Results For Second Quarter 2016

Second Quarter Revenues of $10.4M grew 62% over prior year

AxoGen Becomes Oversold (AXGN)

AxoGen Becomes Oversold (AXGN)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

3 Stocks Under $10 to Trade for Breakouts

3 Stocks Under $10 to Trade for Breakouts

These under-$10 stocks are within range of triggering breakout trades.